Literature DB >> 9265867

Wegener granulomatosis causing sellar mass, hydrocephalus, and global pituitary failure.

R D Bertken1, V R Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9265867      PMCID： PMC1304416     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  14 in total

Review 1.  Less common manifestations and presentations of Wegener's granulomatosis.

Authors:  R Y Leavitt; A S Fauci
Journal:  Curr Opin Rheumatol       Date:  1992-02       Impact factor: 5.006

2.  Sulfonamides as antiinflammatory agents in the treatment of Wegener's granulomatosis.

Authors:  D E Roberts; J G Curd
Journal:  Arthritis Rheum       Date:  1990-10

3.  Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole.

Authors:  K de Groot; E Reinhold-Keller; E Tatsis; J Paulsen; M Heller; B Nölle; W L Gross
Journal:  Arthritis Rheum       Date:  1996-12

4.  The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis.

Authors:  J K Rao; M Weinberger; E Z Oddone; N B Allen; P Landsman; J R Feussner
Journal:  Ann Intern Med       Date:  1995-12-15       Impact factor: 25.391

5.  A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis.

Authors:  J K Rao; N B Allen; J R Feussner; M Weinberger
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

6.  Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis.

Authors:  G S Kerr; T A Fleisher; C W Hallahan; R Y Leavitt; A S Fauci; G S Hoffman
Journal:  Arthritis Rheum       Date:  1993-03

7.  Sulfamethoxazole-trimethoprim therapy for Wegener's granulomatosis.

Authors:  H L Israel
Journal:  Arch Intern Med       Date:  1988-10

8.  Two cases of Wegener's granulomatosis involving the pituitary.

Authors:  G A Roberts; E Eren; H Sinclair; M Pelling; A Burns; R Bradford; R Maurice-Williams; C M Black; N Finer; P M Bouloux
Journal:  Clin Endocrinol (Oxf)       Date:  1995-03       Impact factor: 3.478

9.  Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study.

Authors:  A A Drosos; L I Sakkas; A Goussia; K C Siamopoulos; H M Moutsopoulos
Journal:  J Intern Med       Date:  1992-09       Impact factor: 8.989

Review 10.  Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee.

Authors:  G Anderson; E T Coles; M Crane; A C Douglas; A R Gibbs; D M Geddes; E T Peel; J B Wood
Journal:  Q J Med       Date:  1992-06
View more
  8 in total

1.  A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis.

Authors:  Hironori Bando; Genzo Iguchi; Hidenori Fukuoka; Masaaki Taniguchi; Seiji Kawano; Miki Saitoh; Kenichi Yoshida; Ryusaku Matsumoto; Kentaro Suda; Hitoshi Nishizawa; Michiko Takahashi; Akio Morinobu; Eiji Kohmura; Wataru Ogawa; Yutaka Takahashi
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

Review 2.  Pituitary involvement in patients with granulomatosis with polyangiitis: case series and literature review.

Authors:  Yu Gu; Xuefeng Sun; Min Peng; Ting Zhang; Juhong Shi; Jiangfeng Mao
Journal:  Rheumatol Int       Date:  2019-06-15       Impact factor: 2.631

Review 3.  Pituitary involvement in Wegener's granulomatosis.

Authors:  Tuck Y Yong; Jordan Y Z Li; Lisa Amato; Kumar Mahadevan; Patrick J Phillips; Penelope S Coates; P Toby H Coates
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

4.  Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature.

Authors:  Audrey De Parisot; Xavier Puéchal; Corinne Langrand; Gerald Raverot; Helder Gil; Laurent Perard; Guillaume Le Guenno; Sabine Berthier; Olivier Tschirret; Jean Paul Eschard; Stephane Vinzio; Loïc Guillevin; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 5.  Pituitary Involvement in Granulomatosis with Polyangiitis: A Retrospective Analysis in a Single Chinese Hospital and a Literature Review.

Authors:  Shixuan Liu; Yan Xu; Naishi Li; Shi Chen; Shangzhu Zhang; Linyi Peng; Wei Bai; Jinglan Wang; Jinming Gao; Xiaofeng Zeng; Juhong Shi; Mengzhao Wang
Journal:  Int J Endocrinol       Date:  2019-11-06       Impact factor: 3.257

Review 6.  Granulomatosis with polyangiitis in a patient with polydipsia, facial nerve paralysis, and severe otologic complaints: a case report and review of the literature.

Authors:  Lukas Koenen; Ulf Elbelt; Heidi Olze; Sören Zappe; Steffen Dommerich
Journal:  J Med Case Rep       Date:  2022-07-28

Review 7.  Pituitary dysfunction in granulomatosis with polyangiitis.

Authors:  Arturo Vega-Beyhart; Irene Rocío Medina-Rangel; Andrea Hinojosa-Azaola; Milagros Fernández-Barrio; Ana Sofía Vargas-Castro; Lucía García-Inciarte; Alberto Guzmán-Pérez; Tania Raisha Torres-Victoria; Froylán David Martínez-Sánchez; Mireya Citlali Pérez-Guzmán; José Miguel Hinojosa-Amaya; Andrés León-Suárez; Miguel Angel Gómez-Sámano; Francisco Javier Gómez-Pérez; Daniel Cuevas-Ramos
Journal:  Clin Rheumatol       Date:  2019-08-24       Impact factor: 2.980

Review 8.  Severe localised granulomatosis with polyangiitis (Wegener's granulomatosis) manifesting with extensive cranial nerve palsies and cranial diabetes insipidus: a case report and literature review.

Authors:  James E Peters; Vivek Gupta; Ibtisam T Saeed; Curtis Offiah; Ali S M Jawad
Journal:  BMC Neurol       Date:  2018-05-01       Impact factor: 2.474
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.